iBio
IBIO
#10296
Rank
C$73.59 M
Marketcap
C$1.04
Share price
-4.00%
Change (1 day)
-32.29%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2026 (TTM): C-$1.06

According to iBio's latest financial reports the company's current EPS (TTM) is C-$1.07. In 2025 the company made an earnings per share (EPS) of C-$2.50 an increase over its 2024 EPS that were of C-$9.28.

EPS history for iBio from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$1.06-57.37%
2025C-$2.50-73.08%
2024C-$9.28-93.88%
2023C-$151.60-8.14%
2022C-$165.0392.67%
2021C-$85.66-80.33%
2020C-$435.42-35.11%
2019C-$670.98-38.96%
2018C-$1,099-6.1%
2017C-$1,17136.67%
2016C-$856.5733.33%
2015C-$642.4350%
2014C-$428.29-53.85%
2013C-$927.95-7.14%
2012C-$999.33-64.1%
2011C-$2,78477.27%
2010C-$1,570144.44%
2009C-$642.4312.93%
2008C-$568.8912.2%
2007C-$507.03

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.54-990.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
C-$0.74-30.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
C-$9.57 793.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C-$7.20 572.00%๐Ÿ‡บ๐Ÿ‡ธ USA